DSW Inc (DSW) 23.14 $DSW Apparel Stores Stocks Under

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DSW Inc (DSW) 23.14 $DSW

Apparel Stores Stocks Under Scanner -- Abercrombie & Fitch, DSW Inc., Tailored Brands, and Francesca's
PR Newswire - 1 hr 20 mins ago
Stock-Callers.com takes a look at the Apparel Stores space which is constantly enhancing its business models to attract new customers; cater to changing preferences; keep up with technological trends; and introduce fresh ideas and designs. Under assessment are the following brands: Abercrombie & Fitch Co. (NYSE: ANF), DSW Inc. (NYSE: DSW), Tailored Brands Inc. (NYSE: TLRD), and Francesca's Holdings Corp. (NASDAQ: FRAN). You can access of our complimentary research reports on these stocks now at:
DSW: 23.14 (+0.09), ANF: 20.11 (+0.29), TLRD: 14.11 (+0.18), FRAN: 12.31 (-0.18)

Designer Shoe Warehouse Expands DSW Kids Nationwide
PR Newswire - Thu Jul 28, 7:00AM CDT
DSW Inc. (NYSE: DSW), announces the launch of DSW Kids in over 200 stores in 40 states across the country. The retail expansion will include footwear for kids of all ages from infants and toddlers through teens. An extension of its successful e-commerce shop, DSW Kids is now open in over 200 brick and mortar locations. Twenty-one new stores opening this fall will also offer DSW Kids.
DSW: 23.14 (+0.09)

SmarTrend Watching for Potential Pullback in Shares of DSW After 1.81% Gain
Comtex SmarTrend(R) - Mon Jul 18, 4:22PM CDT
DSW (NYSESW) traded in a range yesterday that spanned from a low of $23.83 to a high of $24.34. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $24.09 on volume of 553,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DSW: 23.14 (+0.09)

Ashland's (ASH) Valvoline Gets New CFO Before Planned IPO
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:05AM CDT
Ashland Inc. (ASH) has appointed Mary Meixelsperger as the new Chief Financial Officer ("CFO" of its current fully-owned subsidiary, Valvoline Inc.
DSW: 23.14 (+0.09), ASH: 113.80 (+0.13), DQ: 25.45 (+1.47), AGFS: 6.11 (+0.21)

Feetz Announces a Strategic Partnership with DSW Inc. to Bring Custom Fit 3D Printed Shoes to the Masses
PR Newswire Europe - Wed Jun 08, 5:00AM CDT
Feetz, the first company to use 3D printing technology to make custom fit, sustainably made shoes for every pair of feet, announced today that it has entered into a strategic partnership with leading footwear retailer DSW Inc. . Together the two companies plan to use Feetz' technology and DSW Inc.'s considerable retail footprint and customer base to bring affordable custom fit, sustainably made shoes to consumers.
DSW: 23.14 (+0.09)

Ashland announces hiring of Mary Meixelsperger as chief financial officer of Valvoline Inc.
Globe Newswire - Tue Jun 07, 7:00AM CDT
June 7, 2016
ASH: 113.80 (+0.13), DSW: 23.14 (+0.09)

DSW Continues to Give Back through its Shoe Lovers Care Philanthropic Platform with Focus on Kids Non-Profits
PR Newswire - Tue Jun 07, 6:00AM CDT
DSW Inc. (NYSE: DSW), a leading branded footwear and accessories retailer, announced the company will be giving back to the community once again through its Shoe Lovers Care Leave Your Mark program. DSW associates nominated non-profit organizations that have made an impression on their lives. Finalists will receive $5,000 and the organization with the most number of votes will receive a $75,000 donation. The public is invited to learn more about the nominated organizations and cast a vote on ShoeLoversCare.com. Voting is currently open to the public and ends on June 14 at 11:59 p.m. ET. Supporters can also share their vote on Facebook and Twitter with #DSWShoeLoversCare to promote the Leave Your Mark campaign.
DSW: 23.14 (+0.09)

DSW Inc. Announces Resignation of Chief Financial Officer, Appoints Interim CFO
PR Newswire - Mon Jun 06, 3:15PM CDT
DSW Inc. (NYSE: DSW), announced that Mary Meixelsperger, DSW's Senior Vice President and Chief Financial Officer, has resigned from the Company effective on June 10, 2016 to pursue another opportunity.
DSW: 23.14 (+0.09)

Moving Average Crossover Alert: DSW Inc. (DSW)
Zacks Equity Research - Zacks Investment Research - Tue May 31, 9:53AM CDT
DSW Inc. (DSW) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
DSW: 23.14 (+0.09)

DSW Inc (DSW) Worth Watching: Stock Adds 6.6% in Session
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:35AM CDT
DSW Inc. (DSW) was a big mover last session, as the company saw its shares rise around 6% on the day.
DSW: 23.14 (+0.09), PLCE: 79.80 (-0.40)

Why did Express (EXPR) Close Over 8% Down on the Day?
Andrew Steele - Zacks Investment Research - Wed May 25, 5:06PM CDT
The retail industry is becoming quite volatile as even the slightest potential concern with a company's earnings report can cause its stock to fall. Express also is feeling the wrath.
DSW: 23.14 (+0.09), LB: 72.52 (+0.26), EXPR: 14.36 (+0.02), JWN: 41.61 (+0.87), GPS: 25.01 (+0.80)

Downtrend Call Working As DSW Stock Falls 18.4% (DSW)
Comtex SmarTrend(R) - Wed May 25, 1:32PM CDT
SmarTrend identified a Downtrend for DSW (NYSESW) on April 25th, 2016 at $24.97. In approximately 1 month, DSW has returned 18.42% as of today's recent price of $20.37.
DSW: 23.14 (+0.09)

DSW Inc (DSW) Plunges 11% on Q1 Earnings & Revenue Miss
Zacks Equity Research - Zacks Investment Research - Wed May 25, 8:33AM CDT
Shares of DSW Inc. (DSW) plunged more than 11% yesterday after the company posted lower-than-expected financial numbers for first-quarter fiscal 2016.
DXLG: 4.81 (-0.01), DSW: 23.14 (+0.09), CENT: 26.09 (+2.17), PLCE: 79.80 (-0.40)

Toll Brothers and JPMorgan rise, CF Industries slumps
AP - Tue May 24, 3:29PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:
NDSN: 88.31 (+0.36), DSW: 23.14 (+0.09), KIRK: 15.27 (+0.10), BBY: 33.41 (+0.55), TWTR: 17.56 (-0.05), TOL: 27.50 (+0.25)

DSW Set to Possibly Rebound After Yesterday's Selloff of 12.72%
Comtex SmarTrend(R) - Tue May 24, 1:51PM CDT
DSW (NYSESW) traded in a range yesterday that spanned from a low of $18.51 to a high of $19.85. Yesterday, the shares fell 12.7%, which took the trading range below the 3-day low of $20.84 on volume of 10.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DSW: 23.14 (+0.09)

Why is DSW (DSW) Stock Tanking Today?
Madeleine Johnson - Zacks Investment Research - Tue May 24, 10:45AM CDT
On Tuesday, shares of specialty branded shoe retailer DSW Inc. (DSW) are tanking, down almost 12% in mid-morning trading after the company reported disappointing first quarter financial results.
DSW: 23.14 (+0.09)

DSW Inc. Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 24, 6:00AM CDT
DSW Inc. (NYSE: DSW), a leading branded footwear and accessories retailer, announced financial results for the thirteen week period ended April 30, 2016, which compares to the thirteen week period ended May 2, 2015.
DSW: 23.14 (+0.09)

Don’t Get Caught With this Retailer in Your Portfolio
ESTMZ - Mon May 23, 3:05PM CDT
DSW Inc. ( DSW ) Consumer Discretionary - Specialty Retail | Reports May 24, Before Market Opens Key Takeaways The Estimize consensus is calling for earnings of 47 cents per share on $698.75 million in revenue, 1 cent higher than Wall Street on...
DSW: 23.14 (+0.09), AMZN: 755.26 (+0.62), NKE: 55.10 (+0.35), JCP: 9.14 (+0.01), M: 33.43 (+0.67), FL: 58.56 (+0.34), FINL: 21.51 (+0.30)

This Retailer is Driving Away with Earnings
ESTMZ - Mon May 23, 3:01PM CDT
AutoZone Inc ( AZO ) Consumer Discretionary - Specialty Retail | Reports May 24, Before Market Opens Key Takeaways The Estimize consensus is calling for earnings per share $11.01 on $2.66 billion in revenue, 5 cents higher than Wall Street on...
DSW: 23.14 (+0.09), AAP: 168.65 (+2.04), AZO: 804.91 (+2.38), COST: 166.12 (-0.38), WMT: 73.00 (+0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading